Intelligent Oncolytic Virus Therapy Platform

A novel system integrating oncolytic viruses with AI, IoT, blockchain, and advanced biomaterials for personalized, adaptive, and secure cancer treatment.

The original patent disclosed an innovative method for enhancing the antitumor effect of oncolytic viruses using oxaliplatin. However, it had limitations in terms of personalized treatment, real-time monitoring, and secure data management. The new inventive concept addresses these limitations by integrating the patented method with cutting-edge technologies.

The Intelligent Oncolytic Virus Therapy Platform comprises five key components: (1) an oncolytic virus growth module integrated with an AI-powered genomics analysis platform, (2) IoT-enabled biosensors for real-time monitoring, (3) a blockchain-based decentralized data management system, (4) a composite biomaterial for targeted virus delivery, and (5) a machine learning model for predicting virus resistance. These components work together to provide personalized treatment regimens, adaptive virus strain selection, and secure data management.

The new claims introduce a synergistic combination of oncolytic viruses with AI, IoT, blockchain, and advanced biomaterials, which is not obvious from the original patent. The integration of these distinct technologies enables a novel system for personalized, adaptive, and secure cancer treatment.

Alternative embodiments may include using different AI algorithms, IoT sensor configurations, or blockchain protocols. Variations may involve incorporating additional technologies, such as CRISPR gene editing or nanotechnology, to further enhance the platform's capabilities.

The Intelligent Oncolytic Virus Therapy Platform has significant commercial potential in the cancer treatment market, with potential applications in personalized medicine, precision oncology, and digital health. The market for oncolytic virus therapy is expected to grow substantially in the coming years, driven by increasing demand for effective and targeted cancer treatments.